For years, the idea of activating glucagon receptors for weight loss seemed counterintuitive since glucagon raises blood sugar
Noom said it is working with an FDA-regulated 503B compounding pharmacy to provide its medication for its new program, which is called Noom GLP-1 RX
Although EHR-recorded weight loss was generally less than the self-reported values, several factors may explain this discrepancy
IQVIA Payer Control Library The Bottom Line The GLP-1 market sits at the intersection of clinical innovation and patient behavior, where real-world persistence often falls short of therapeutic potential
Participants were excluded if they used these drugs in the year before enrolment or had contraindications to them
On Ozempic (semaglutide 0.5-2.0 mg, primarily for Type 2 diabetes management): A February 2026 study published in the Journal of Clinical Endocrinology & Metabolism (Kasher Meron et al.) examined fragility fracture rates in adults aged 65 and older with Type 2 diabetes who started GLP-1 medications versus those taking other diabetes medications
